Henry Ford Health begins enrollment in hydroxychloroquine study to combat COVID-19
DETROIT (WXYZ) Henry Ford Health System has started enrollment in a study of the effectiveness of the anti-malarial drug hydroxychloroquine in preventing the coronavirus (COVID-19). It’s the first large-scale study of the drug in the United States.
That’s great news!